27
total announcements
SYNGENE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹15,976 Cr
P/E (TTM)
72.4
P/E (Forward)
37.1
EPS (TTM)
₹5.49
52W Low
₹344.45
52W High
₹678.95
Dividend Yield
0.32%
Beta
0.07
Price / Book
3.3
Debt / Equity
9.5
Revenue (TTM)
₹3,600 Cr
Gross Margin
68.00%
Operating Margin
3.90%
Syngene International Ltd
Syngene International Ltd, a biotechnology company, has announced a conference call for analysts and investors to discuss its Q2 FY 2026-27 financial results. The call will be held on October 28, 2026, and will be conducted over Zoom. The company will also provide an audio recording and transcript of the call on its website.
Syngene International Ltd
Syngene International Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities during the quarter ended September 30, 2026.
Syngene International Ltd
Syngene International Ltd has scheduled a Board Meeting on October 27, 2026, to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ending September 30, 2026.
Syngene International Ltd
Syngene International Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half-year ending September 30, 2026, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading.
Syngene International Ltd
Syngene International Ltd has cancelled a meeting with Bajaj AMC, scheduled for September 24, 2026, as per their earlier intimation on September 5, 2026.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited has informed the BSE about a change in key personnel, specifically the cessation of SMP as Head Corporate Affairs and Communications and a member of the Executive Committee.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited has informed the BSE about the cessation of SMP, Head Corporate Affairs and Communications, and a member of the Executive Committee.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited has informed the BSE about the cessation of SMP as Head Corporate Affairs and Communications and a member of the Executive Committee.
Syngene International Ltd
Syngene International Ltd has announced the resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee, effective September 21, 2026, to pursue other career opportunities.
Syngene International Ltd
Syngene International Ltd has announced a meeting with analysts and institutional investors on September 17, 2026, at 09:00 AM in Mumbai, organized by Kotak (Investor Conference). The company will not disclose any unpublished price sensitive information during the meeting.
Syngene International Ltd
Syngene International Ltd has granted 14,26,061 Performance Share Units to eligible employees under the Syngene Long Term Incentive Performance Share Plan 2023.
Syngene International Ltd
Syngene International Ltd has announced a meeting with Goldman Sachs Asia Leaders Conference 2026, scheduled for August 31 and September 1, 2026, in Hong Kong. The company will not disclose any unpublished price-sensitive information during the meeting.
Syngene International Ltd
Syngene International Ltd has acquired an equity stake in Ampin C&I Power Twelve Private Limited for renewable power generation, aligning with its renewable energy objectives and decarbonization goals.
Syngene International Ltd
Syngene International Ltd has announced an investor call schedule with Entrust Family Office on August 28, 2026, and has stated that no unpublished price-sensitive information will be disclosed during the meeting.
Syngene International Ltd
Syngene International Ltd has announced a meeting with analysts and institutional investors on August 13 and 14, 2026, organized by Emkay Global. The company will not disclose any unpublished price sensitive information during the meeting.
Syngene International Ltd
Syngene International Ltd has announced the transcript of its Q1 FY2027 Earnings Conference call, which is available on the company's website.
Syngene International Ltd
Syngene International Ltd's 33rd Annual General Meeting (AGM) voting results and Scrutinizer's Report have been submitted. All 9 resolutions were approved with the requisite majority by the shareholders. The details of votes cast by shareholders are given in the attached Annexure A. The results of e-voting along with Scrutinizer's Report are also available on the Company's website and on the website of Kfin Technologies Limited, the Register and Share Transfer Agents.
Syngene International Ltd
Syngene International Ltd has announced the availability of the audio recording of its Q1 FY27 post-earnings call, which was conducted on July 30, 2026, and uploaded on the company's website.
Syngene International Ltd
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue at ₹7,360 crore, profit before tax at ₹4,875 crore, and profit after tax at ₹1,013 crore.
Syngene International Ltd
Syngene International Ltd has released an investor presentation for Q1 FY27, highlighting a 16% Y-o-Y decline in revenue from operations to Rs 736 Cr, with EBITDA margin at 12% (24% in Q1 FY26). The company has strengthened its AI-enabled scientific platform, Syngene's AI-enabled scientific platform for accelerating drug discovery services, and has been recognized as one of the world's top 750 most sustainable companies for the second consecutive year.